Brickell starts pivotal Phase III trial of drug candidate in US,

Brickell Biotech Inc. (Nasdaq: BBI) has kicked off its final clinical trial in the U.S. for its anti-underarm sweating treatment. In a statement, the Boulder …, Brickell Biotech Inc. (Nasdaq: BBI) has kicked off its final clinical trial in the U.S. for its anti-underarm sweating treatment. In a statement, the Boulder …, Read More